Filtros de búsqueda

Lista de obras de Christine E Hallgreen

A comprehensive approach to benefit-risk assessment in drug development.

artículo científico publicado en 2012

Allometric relationship between changes of visceral fat and total fat mass

artículo científico publicado en 2007

Are monitoring instructions provided in direct healthcare professional communications (DHPCs) of sufficient quality? A retrospective analysis of DHPCs sent out between 2007 and 2018

artículo científico publicado en 2020

Balancing benefit and risk of medicines: a systematic review and classification of available methodologies

artículo científico publicado en 2014

Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology.

artículo científico publicado en 2014

Differences and similarities in medicine use, perceptions and sharing among adolescents in two different educational settings

artículo científico publicado en 2017

How and Why to Involve Patients in Drug Development: Perspectives From the Pharmaceutical Industry, Regulatory Authorities, and Patient Organizations

scientific article published on 07 August 2019

How and Why to Involve Patients in Drug Development: Perspectives From the Pharmaceutical Industry, Regulatory Authorities, and Patient Organizations

scientific article published on 06 January 2020

Literature review of visual representation of the results of benefit-risk assessments of medicinal products

artículo científico publicado en 2015

Recommendations for benefit-risk assessment methodologies and visual representations

artículo científico publicado en 2016

Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance.

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda